Published by Sean Farrell on 1st February 2022
(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK company.
URL: http://www.digitallook.com/dl/news/story/32430464/...